Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Science
  3. Research Sites

Main Research and Development Centers

Each of our R&D centers specializes in a different area of scientific exploration. We have several major campuses located throughout the U.S. and U.K.

Andover, Massachusetts Research Site front entrance
Andover, Massachusetts

A 70-acre site that combines state-of-the-art R&D facilities with flexible, multi-product manufacturing capabilities.

Cambridge, Massachusetts Research Site building
Cambridge, Massachusetts

Located in Kendall Square, our Cambridge site interlaces Pfizer’s R&D capability with the densest biomedical community in the world.

Aerial view of Groton, Connecticut research site
Groton, Connecticut

As the company’s largest R&D facility, Groton is involved in the development of nearly every Pfizer medicine and vaccine.

La-Jolla.webp
La Jolla, California

With more than 500,000 square feet of state-of-the-art facilities, this is where our scientists discover and develop cutting-edge cancer therapies using advanced laboratories and equipment.

Pearl River, New York Research Site campus aerial view
Pearl River, New York

The primary location for our company’s global Vaccine Research and Development work.

Sandwich, UK Research Site building front
Sandwich, UK

Home of the Pharmaceutical Sciences and Global Regulatory Affairs groups.

St. Louis, MO Research Site front entrance
St. Louis, MO

A 300,000 sq. ft. facility producing innovative emergency care products that serve unique needs during severe medical crises.

Pipeline Snapshot as of February 3, 2026
Explore the Product PipelineDownload Complete Pipeline PDF
pipeline animated GIF lines loading in 3D

Clinical Trials

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details

Related Articles

Science & Innovation

How AI Is Already Reshaping Cancer Care

When treating cancer, timing is everything. AI is helping identify clinical trial participants earlier, accelerate discovery, and expand access to investigational therapies.

A group of doctors listening to a research presentation in hospital thumbnail

Science & Innovation

Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection

For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.

Elderly man speaking with healthcare professional thumbnail

Science & Innovation

As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever

At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.

Up close image of a cell, thumbnail
Search More Stories
See More